Literature DB >> 114357

Immunology of the nicotinic acetylcholine receptor.

S Fuchs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114357     DOI: 10.1007/978-3-642-67322-1_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  6 in total

1.  Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.

Authors:  N Venkatesh; S H Im; M Balass; S Fuchs; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.

Authors:  D Barchan; M C Souroujon; S H Im; C Antozzi; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.

Authors:  G Goldberg; D Mochly-Rosen; S Fuchs; Y Lass
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

5.  Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

Authors:  S H Im; D Barchan; S Fuchs; M C Souroujon
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Immune regulation of experimental myasthenia.

Authors:  S Fuchs; D Bartfeld; Z Eshhar; C Feingold; D Mochly-Rosen; D Novick; M Schwartz; R Tarrab-Hazdai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.